Request Deal Involvement

Seattle Genetics acquired Cascadian Therapeutics for $614m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Perella Weinberg Partners

financial advisors

Perella Weinberg Partners

Reed Smith

legal advisors

Reed Smith

Goodwin Procter

legal advisors

Goodwin Procter

Leerink Partners

financial advisors

Leerink Partners

Latham & Watkins

legal advisors

Latham & Watkins

Leerink Partners

financial advisors

Leerink Partners

Sullivan & Cromwell

legal advisors

Sullivan & Cromwell

Barclays

financial advisors

Barclays

JP Morgan

financial advisors

JP Morgan

or

Principals

CASCADIAN THERAPEUTICS INC

target

CASCADIAN THERAPEUTICS INC

SEATTLE GENETICS INC

bidder

SEATTLE GENETICS INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite